Modeling early treatment response in AML from cell-free tumor DNA-Reference-Cited by-同舟云学术

Modeling early treatment response in AML from cell-free tumor DNA

Published:2023-12 Issue:12 Volume:26 Page:108271
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Wang Dantong,Rausch Christian,Buerger Simon A.,Tschuri Sebastian,Rothenberg-Thurley Maja,Schulz Melanie,Hasenauer Jan,Ziemann Frank,Metzeler Klaus H.,Marr Carsten^ORCID

Funder

ERC

European Research Council

China Scholarship Council

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference50 articles.

1. Hematologic Malignancies: Acute Leukemias;Faderl,2007

2. Acute leukemia and chemotherapy: a modeling viewpoint;Afenya;Math. Biosci.,1996

3. New strategies to treat AML: novel insights into AML survival pathways and combination therapies;Nair;Leukemia,2021

4. Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia;Metzeler;Blood,2016

5. Post-remission therapy for acute myeloid leukemia;Schlenk;Haematologica,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical applications of circulating tumor DNA in hematological malignancies: From past to the future;Blood Reviews;2024-09

2. Multi-Class Skin Disease Classification: A Study of Transfer Learning Strategies for Deep Learning Models;2024 International Conference on Signal Processing, Computation, Electronics, Power and Telecommunication (IConSCEPT);2024-07-04

3. Bridging horizons beyond CIRCULATE-Japan: a new paradigm in molecular residual disease detection via whole genome sequencing-based circulating tumor DNA assay;International Journal of Clinical Oncology;2024-03-29